Marco Rimoldi

1.2k total citations
17 papers, 908 citations indexed

About

Marco Rimoldi is a scholar working on Molecular Biology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marco Rimoldi has authored 17 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marco Rimoldi's work include Metabolism and Genetic Disorders (10 papers), Mitochondrial Function and Pathology (7 papers) and Biochemical and Molecular Research (4 papers). Marco Rimoldi is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Mitochondrial Function and Pathology (7 papers) and Biochemical and Molecular Research (4 papers). Marco Rimoldi collaborates with scholars based in Italy, United States and France. Marco Rimoldi's co-authors include Massimo Zeviani, A. Prelle, Valeria Tiranti, Ivano Di Meo, Michael D. Levitt, Cecilia Tiveron, Carlo Viscomi, Gigliola Fagiolari, Tatjana M. Hildebrandt and Rossana Mineri and has published in prestigious journals such as Nature Medicine, Neurology and Annals of Neurology.

In The Last Decade

Marco Rimoldi

17 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Rimoldi Italy 13 621 436 206 128 95 17 908
Sven W. Sauer Germany 19 1.0k 1.7× 911 2.1× 281 1.4× 204 1.6× 164 1.7× 30 1.6k
Ivano Di Meo Italy 21 820 1.3× 531 1.2× 406 2.0× 98 0.8× 183 1.9× 41 1.3k
Stéphanie Gobin France 16 432 0.7× 321 0.7× 61 0.3× 95 0.7× 58 0.6× 27 778
Daria Diodato Italy 18 868 1.4× 535 1.2× 78 0.4× 88 0.7× 215 2.3× 44 1.2k
Teresa Rizza Italy 23 783 1.3× 338 0.8× 67 0.3× 98 0.8× 50 0.5× 43 1.1k
Mauro Scarpelli Italy 17 535 0.9× 312 0.7× 35 0.2× 179 1.4× 99 1.0× 34 796
K. Bartholomé Germany 16 441 0.7× 636 1.5× 162 0.8× 181 1.4× 119 1.3× 27 931
Jan Smeitink Netherlands 13 1.1k 1.8× 587 1.3× 73 0.4× 130 1.0× 40 0.4× 13 1.3k
Markéta Tesařová Czechia 22 1.0k 1.6× 483 1.1× 35 0.2× 109 0.9× 56 0.6× 86 1.3k
Niels Gregersen Denmark 14 630 1.0× 535 1.2× 70 0.3× 176 1.4× 121 1.3× 28 935

Countries citing papers authored by Marco Rimoldi

Since Specialization
Citations

This map shows the geographic impact of Marco Rimoldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Rimoldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Rimoldi more than expected).

Fields of papers citing papers by Marco Rimoldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Rimoldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Rimoldi. The network helps show where Marco Rimoldi may publish in the future.

Co-authorship network of co-authors of Marco Rimoldi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Rimoldi. A scholar is included among the top collaborators of Marco Rimoldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Rimoldi. Marco Rimoldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mariotti, Massimo, Renato Colognato, Marco Rimoldi, et al.. (2015). Mesenchymal Stromal Cells Uptake and Release Paclitaxel without Reducing its Anticancer Activity. Anti-Cancer Agents in Medicinal Chemistry. 15(3). 400–405. 7 indexed citations
2.
Bonomi, Arianna, Daniela Lisini, Stefania Elena Navone, et al.. (2014). Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma. Cytotherapy. 17(3). 310–319. 12 indexed citations
3.
Salsano, Ettore, Silvia Tabano, Silvia Maria Sirchia, et al.. (2012). Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms. Orphanet Journal of Rare Diseases. 7(1). 10–10. 27 indexed citations
4.
Cotelli, Maria Sofia, Valentina Vielmi, Marco Rimoldi, et al.. (2011). Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect. Neurological Sciences. 33(6). 1383–1387. 11 indexed citations
5.
Leoni, Valerio, Laura Strittmatter, Giovanna Zorzi, et al.. (2011). Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations. Molecular Genetics and Metabolism. 105(3). 463–471. 98 indexed citations
6.
Castellotti, Barbara, Caterina Mariotti, Marco Rimoldi, et al.. (2011). Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. Neurogenetics. 12(3). 193–201. 33 indexed citations
7.
Magri, Stefania, et al.. (2010). Preparation of yeast mitochondria and in vitro assay of respiratory chain complex activities. Protocol Exchange. 8 indexed citations
8.
Tiranti, Valeria, Carlo Viscomi, Tatjana M. Hildebrandt, et al.. (2009). Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nature Medicine. 15(2). 200–205. 318 indexed citations
9.
Fabrizi, Gian Maria, Raffaele Lodi, Alessandro Malandrini, et al.. (1996). Autosomal dominant limb girdle myopathy with ragged-red fibers and cardiomyopathy A pedigree study by in vivo 31P-MR spectroscopy indicating a multisystem mitochondrial defect. Journal of the Neurological Sciences. 137(1). 20–27. 9 indexed citations
10.
Mariotti, Caterina, Anu Suomalainen, Marco Rimoldi, et al.. (1995). Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. Journal of Neurology. 242(5). 304–312. 80 indexed citations
11.
Antozzi, Carlo, Silvana Franceschetti, Graziella Filippini, et al.. (1995). Epilepsia partialis continua associated with NADH-coenzyme Q reductase deficiency. Journal of the Neurological Sciences. 129(2). 152–161. 19 indexed citations
12.
Uziel, Graziella, Barbara Garavaglia, Elisa Ciceri, Isabella Moroni, & Marco Rimoldi. (1995). Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy. Pediatric Neurology. 13(4). 333–335. 22 indexed citations
13.
Muntoni, Francesco, Gualtiero Catani, Anna Mateddu, et al.. (1994). Familial cardiomyopathy, mental retardation and myopathy associated with desmin-type intermediate filaments. Neuromuscular Disorders. 4(3). 233–241. 44 indexed citations
14.
Uziel, Graziella, et al.. (1991). Experience on Therapy of Adrenoleukodystrophy and Adrenomyeloneuropathy. Developmental Neuroscience. 13(4-5). 274–279. 44 indexed citations
15.
DiDonato, Stefano, Cinzia Gellera, D. Peluchetti, et al.. (1989). Normalization of short‐chain acylcoenzyme a dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme a dehydrogenase—deficient myopathy. Annals of Neurology. 25(5). 479–484. 38 indexed citations
16.
Demaugre, France, Jean‐Paul Bonnefont, Grant Mitchell, et al.. (1988). Hepatic and Muscular Presentations of Carnitine Palmitoyl Transferase Deficiency: Two Distinct Entities. Pediatric Research. 24(3). 308–311. 105 indexed citations
17.
Donato, Stefano Di, et al.. (1984). Systemic carnitine deficiency. Neurology. 34(2). 157–157. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven W. Sauer Breakdown of academic impact, for papers by Ivano Di Meo Breakdown of academic impact, for papers by Stéphanie Gobin Breakdown of academic impact, for papers by Daria Diodato Breakdown of academic impact, for papers by Teresa Rizza Breakdown of academic impact, for papers by Mauro Scarpelli Breakdown of academic impact, for papers by K. Bartholomé Breakdown of academic impact, for papers by Jan Smeitink Breakdown of academic impact, for papers by Markéta Tesařová Breakdown of academic impact, for papers by Niels Gregersen
Rankless by CCL
2026